Idexx Laboratories (IDXX) Operating Leases (2019 - 2026)

Idexx Laboratories (IDXX) has reported Operating Leases for 8 consecutive years, with $98.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Operating Leases fell 17.11% year-over-year to $98.7 million; the TTM figure through Mar 2026 stood at $98.7 million (down 17.11% YoY), while the FY2025 annual figure was $101.2 million, up 3.39% from the prior year.
• Operating Leases came in at $98.7 million for Q1 2026 at Idexx Laboratories, down from $101.2 million in the prior quarter.
• The five-year high for Operating Leases was $133.5 million in Q2 2025, with the low at $89.6 million in Q1 2022.
• Average Operating Leases over 5 years is $106.2 million, with a median of $101.2 million recorded in 2022.
• The largest YoY upside for Operating Leases was 30.32% in 2023 against a maximum downside of 17.36% in 2023.
• Year by year, Operating Leases stood at $101.2 million in 2022, then dropped by 1.55% to $99.7 million in 2023, then decreased by 1.84% to $97.8 million in 2024, then rose by 3.39% to $101.2 million in 2025, then retreated by 2.38% to $98.7 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $98.7 million, $101.2 million, and $106.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.